Cite
MLA Citation
Marianne Pouwer et al.. “Cardiovascular safety of BCR-ABL1 tyrosine kinase inhibitors: imatinib and ponatinib decrease plasma cholesterol and atherosclerosis in APOE3*Leiden.CETP Mice.” Atherosclerosis, vol. 263, 2017, pp. e29–e30. http://access.bl.uk/ark:/81055/vdc_100048161150.0x00005b